G
GRI
GRI Bio
1.440
-0.010-0.68%Opening11:57 10/26 EDT
OPEN/PREV CLOSE1.470/1.450
TODAY RANGE1.440-1.470
VOL2.77K
MARKET CAP3.15M
52 WEEK RANGE1.360-64.12
AVG VOL (3M)332.27K
% TURNOVER0.13%
TURNOVER--
P/E (TTM)-0.0279
% RANGE2.06%
EPS(TTM)-51.6532
P/E(FORWARD)-0.3697
P/B0.3062
BVPS4.702
DIVIDEND--
P/S476.19
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.14M
SHARES OUTSTANDING2.19M
NEXT EARNINGS11/12-11/16
FREE FLOAT2.18M
LOT SIZE1
EX-DATE01/26/2026
News
Press Releases
Financial Reports
Profile
TipRanks·10/13 15:15
Bristol Phase 3 win underscores opportunity for GRI Bio, says H.C. Wainwright
Benzinga·10/02 12:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Dow Jones·09/10 17:34
GRI Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
Benzinga·09/10 17:24
HC Wainwright & Co. Reiterates Buy on GRI Bio, Maintains $10 Price Target
Benzinga·09/08 17:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
TipRanks·09/08 12:55
GRI Bio announces new translational biomarker data from GRI-0621-IPF-02 study
TipRanks·09/08 12:47
GRI Bio Reports Positive Phase 2a IPF Biomarker Data
Benzinga·09/04 17:06
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·09/03 17:06
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·08/24 09:54
GRI Bio Price Target Cut to $27.00/Share From $32.00 by Ascendiant Capital
Dow Jones·08/24 09:54
GRI Bio Is Maintained at Buy by Ascendiant Capital
Benzinga·08/11 17:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·07/20 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·06/18 23:11
GRI Bio Secures FDA Orphan Drug Status for IPF
TipRanks·06/18 13:05
GRI Bio announces U.S. FDA granted ODD to GRI-0621
Same Industry
Name/Symbol
Change%
Price